Sanara MedTech logo
Sanara MedTech
SMTI | NASDAQ
Chart Builder DCF Calculator
$32.76
+$0.41 (+1.27%)
At close: Nov 16, 2026, 4:00 PM ET
$32.76
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:15 PM ET

Sanara MedTech Company Profile

Company profile explained

Company Profile

Sanara MedTech Inc. is a Fort Worth, Texas-based company established in 2001, dedicated to the development, marketing, and distribution of advanced wound and skin care products. These solutions are provided to a diverse clientele within the United States healthcare sector, including physicians, hospitals, clinics, and post-acute care facilities. The company's extensive product portfolio includes CellerateRX, a line of Surgical Activated Collagen in both powder and gel forms, designed to enhance patient healing across various surgical specialties. Sanara MedTech also offers a suite of Biako's antimicrobial products: a patented Skin and Wound Cleanser engineered to dismantle mature biofilm microbes by disrupting their extracellular polymeric substances, an Antimicrobial Wound Gel effective against both planktonic and biofilm-forming microbes, and an Antimicrobial Skin and Wound Irrigation Solution. Another key offering is HYCOL, a hydrolyzed Type I bovine collagen available as powder and gel, specifically formulated for the management of both full and partial thickness wounds, encompassing conditions such as pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. Additionally, Sanara MedTech is involved in the development of sophisticated biologic devices like FORTIFY TRG, a freeze-dried, multi-layer sheet derived from small intestinal submucosa extracellular matrix, and FORTIFY FLOWABLE extracellular matrix, an innovative wound care solution. The company also provides VIM Amnion Matrix, a single-layer amnion tissue sheet. Initially incorporated as WNDM Medical Inc., the company underwent a name change to Sanara MedTech Inc. in May 2019.

Key Executives

Name Position
Seth Yon President, Chief Executive Officer & Director
Suresh V. Muppalla President & Chief Executive Officer of THP
Elizabeth Taylor Chief Financial Officer
Jacob A. Waldrop Chief Operating Officer
Ashley Mackey Principal Accounting Officer
Bill Fitzgerald Chief Compliance Officer
Nicholas Gachassin General Counsel
Nina Bionda Chief R&D Officer
Ronald T. Nixon Executive Chairman
Tricia Matteson Vice President of Marketing
Tyler Palmer Chief Corporate Development & Strategy Officer

Latest SEC Filings

Date Type Title
Oct 29, 2026 8-K Current Report
Oct 28, 2026 425 Filing
Oct 16, 2026 425 Filing
Oct 16, 2026 8-K Current Report
Oct 16, 2026 425 Filing
Oct 01, 2026 8-K Current Report
Sep 16, 2026 4 Filing
Sep 04, 2026 DEFM14A Filing
Aug 20, 2026 425 Filing
Aug 11, 2026 10-Q Quarterly Report
View All SEC Filings ➞
Sanara MedTech
Sanara MedTech logo
Country United States
IPO Date Apr 7, 1994
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 108
CEO Seth D. Yon

Contact Details

1200 Summit Avenue Fort Worth, Texas 76102 United States

Stock Details

Ticker Symbol SMTI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000714256
CUSIP Number 79957L100
ISIN Number US79957L1008
SIC Code 3842

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.